dapagliflozinsaxagliptinmetformin sold brand name qternmet xr among others fixeddose combination antidiabetic medication used adjunct diet exercise improve glycemic control adults type combination dapagliflozin saxagliptin taken drug marketed common side effects include infections nose throat hypoglycaemia low blood sugar used sulphonylurea effects gut nausea feeling sick vomiting diarrhoea abdominal tummy pain loss dapagliflozinsaxagliptinmetformin approved medical use united states may european union november marketing authorisation withdrawn european union august approval withdrawn us april cases request united states dapagliflozinsaxagliptinmetformin indicated adjunct diet exercise improve glycemic control adults type european union indicated adults aged years older type diabetes mellitus drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikidapagliflozinsaxagliptinmetformin